Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

27.75
0.0000
Volume:26
Turnover:725.23
Market Cap:971.12K
PE:- -
High:27.75
Open:27.75
Low:27.75
Close:27.75
52wk High:29.89
52wk Low:24.32
Shares:35.00K
Float Shares:35.00K
Volume Ratio:0.00
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

States Namenda Tablets not Withdrawn for Safety or Effectiveness Reasons - Federal Register

THOMSON REUTERS
·
Aug 31

FDA: Will not Begin Procedures to Withdraw Approval of Abbreviated New Drug Applications That Refer to Namenda Products - Federal Register

THOMSON REUTERS
·
Aug 31

AbbVie to Present at Wells Fargo Healthcare Conference

Reuters
·
Aug 31

CICC Upgrades Estee Lauder Companies to Outperform From Neutral, Adjusts PT to $122 From $65

MT Newswires Live
·
Aug 31

Estee Lauder upgraded to Outperform from Market Perform at CICC

TIPRANKS
·
Aug 30

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan

TIPRANKS
·
Aug 29

Ulta Beauty Stock Falls After Upbeat Earnings

Dow Jones
·
Aug 28

Deals of the Day-Mergers and Acquisitions

Reuters
·
Aug 28

Kimberly-Clark Files for EU Antitrust Approval of Kenvue Takeover

MT Newswires Live
·
Aug 28

Argus Raises Estee Lauder Price Target to $125 From $100

MT Newswires Live
·
Aug 28

Preview: Ulta's Q2 EPS, Rev Seen Rising but Shares Slip

Reuters
·
Aug 28

China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs

Reuters
·
Aug 27

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Reuters
·
Aug 27

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS
·
Aug 27

Ulta Beauty Earnings are Coming After an Ugly Stock Selloff

Dow Jones
·
Aug 27

AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 27

Kenvue Says Kenvue Cares Week Volunteer Program Logs 7,750 Hours in 2026 Healthy Lives Mission Report

Reuters
·
Aug 26